Overview:

Summary

Clinical trial report, “Fragile X Syndrome Global Clinical Trials Review, Q1, 2011"" provides data on the Fragile X Syndrome clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Fragile X Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Fragile X Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status and trial success rate
- Review of key discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication as a whole
- Examine the performance of the trials in terms of their status, recruitment, success rates and others
- Obtain discontinued trial information for trials across the globe
- Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Fragile X Syndrome 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by Phase 13
In Progress Trials by Phase 14
Clinical Trials by Trial Status 15
Subjects Recruited Over a Period of Time 16
Prominent Sponsors 17
Top Companies Participating in Fragile X Syndrome Therapeutics Clinical Trials 18
Prominent Drug Comparison 19
Clinical Trial Profiles 20
Clinical Trial Overview of Top Companies 20
Seaside Therapeutics 20
Clinical Trial Overview of Seaside Therapeutics 20
Neuropharm Group Plc 21
Clinical Trial Overview of Neuropharm Group Plc 21
Cortex Pharmaceuticals, Inc. 22
Clinical Trial Overview of Cortex Pharmaceuticals, Inc. 22
Novartis AG 23
Clinical Trial Overview of Novartis AG 23
Clinical Trial Overview of Top Universities / Institutes / Hospitals 24
Stanford University 24
Clinical Trial Overview of Stanford University 24
Fragile X Research Foundation of Canada 25
Clinical Trial Overview of Fragile X Research Foundation of Canada 25
Indiana University 26
Clinical Trial Overview of Indiana University 26
Seaside Therapeutics 27
Clinical Trial Overview of Seaside Therapeutics 27
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 28
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 28
Indiana University School of Medicine 29
Clinical Trial Overview of Indiana University School of Medicine 29
All India Institute of Medical Sciences 30
Clinical Trial Overview of All India Institute of Medical Sciences 30
Massachusetts General Hospital 31
Clinical Trial Overview of Massachusetts General Hospital 31
University of California, Davis 32
Clinical Trial Overview of University of California, Davis 32
Rabin Medical Center 33
Clinical Trial Overview of Rabin Medical Center 33
Appendix 34
Abbreviations 34
Definitions 34
Research Methodology 35
Secondary Research 35
About GlobalData 36
Contact Us 36
Disclaimer 37
Source 37

List of Tables
Fragile X Syndrome Therapeutics Market, Global, Clinical Trials by Zone, 2011* 7
Fragile X Syndrome Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 8
Fragile X Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 9
Fragile X Syndrome Therapeutics Clinical Trials, Europe, Top Countries, 2011* 10
Fragile X Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2011* 11
Fragile X Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011* 12
Fragile X Syndrome Therapeutics Market, Global, Clinical Trials by Phase, 2011* 13
Fragile X Syndrome Therapeutics Market, Global, Clinical Trials in Progress by Phase 2011* 14
Fragile X Syndrome Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 15
Fragile X Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 16
Fragile X Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 17
Fragile X Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 18
Fragile X Syndrome Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011** 19
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Seaside Therapeutics, 2011* 20
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Neuropharm Group Plc, 2011* 21
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Cortex Pharmaceuticals, Inc., 2011* 22
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2011* 23
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2011* 24
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Fragile X Research Foundation of Canada, 2011* 25
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University, 2011* 26
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Seaside Therapeutics, 2011* 27
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), 2011* 28
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University School of Medicine, 2011* 29
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2011* 30
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2011* 31
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Davis, 2011* 32
Fragile X Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin Medical Center, 2011* 33

List of Figures
Fragile X Syndrome Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 7
Fragile X Syndrome Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 8
Fragile X Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 9
Fragile X Syndrome Therapeutics Clinical Trials, Europe, Top Countries (%), 2011* 10
Fragile X Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2011* 11
Fragile X Syndrome Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 13
Fragile X Syndrome Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2011* 14
Fragile X Syndrome Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 15
Fragile X Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 16
Fragile X Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 17
Fragile X Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 18
Fragile X Syndrome Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 19
GlobalData Methodology 35